Trial Profile
The Randomized Clinical Trials of Letrozole Administration During Luteal Phase in Patients Who Have the Risk of Ovarian Hyperstimulation Syndrome
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Jul 2023
Price :
$35
*
At a glance
- Drugs Letrozole (Primary) ; Dexamethasone; Polygeline; Sodium chloride
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 18 Jul 2023 Planned End Date changed from 1 Mar 2017 to 1 Dec 2024.
- 18 Jul 2023 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2024.
- 18 Jul 2023 Planned initiation date changed from 1 Apr 2016 to 1 Dec 2023.